Published in J Card Fail on January 06, 2010
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Contemporary strategies in the diagnosis and management of heart failure. Mayo Clin Proc (2014) 0.98
Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care (2014) 0.91
Efficacy and safety of loop diuretic therapy in acute decompensated heart failure: a clinical review. Heart Fail Rev (2014) 0.79
Loop Diuretics in Clinical Practice. Electrolyte Blood Press (2015) 0.78
A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide. Pharm Pract (Granada) (2013) 0.76
Stability of furosemide and chlorothiazide stored in syringes. Am J Health Syst Pharm (2015) 0.75
A prospective, randomized study to evaluate the efficacy of various diuretic strategies in acute decompensated heart failure. Indian Heart J (2014) 0.75
American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy (2006) 9.72
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med (2008) 3.68
The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology (2008) 2.19
Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology (2008) 1.94
Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis. Ann Pharmacother (2008) 1.87
Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med (2008) 1.41
Recipient risk factors for graft failure in the cornea donor study. Ophthalmology (2009) 1.40
Importance of direct patient care in advanced pharmacy practice experiences. Pharmacotherapy (2012) 1.26
The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the Cornea Donor Study. Ophthalmology (2013) 1.23
The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. Ann Pharmacother (2011) 1.12
Multi-institutional study of women and underrepresented minority faculty members in academic pharmacy. Am J Pharm Educ (2012) 0.96
Retrospective review of graft dislocation rate associated with descemet stripping automated endothelial keratoplasty after primary failed penetrating keratoplasty. Cornea (2011) 0.95
Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. Circulation (2005) 0.93
Human B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery. J Card Fail (2004) 0.92
Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann Pharmacother (2009) 0.92
Bosentan for the treatment of pulmonary arterial hypertension. Ann Pharmacother (2003) 0.90
Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs. Med Care (2015) 0.89
Comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty in patients with Fuchs endothelial dystrophy. Cornea (2008) 0.87
Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel. Coron Artery Dis (2009) 0.86
Type 2 diabetes mellitus and heart failure. Pharmacotherapy (2008) 0.85
Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness. J Thromb Thrombolysis (2013) 0.84
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J (2009) 0.83
Clinical update on the management of atrial fibrillation. Pharmacotherapy (2013) 0.81
Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy (2006) 0.80
Acute decompensated heart failure: evolving literature and implications for future practice. Pharmacotherapy (2013) 0.80
Bayesian analysis of recurrent event with dependent termination: an application to a heart transplant study. Stat Med (2012) 0.79
Rhabdomyolysis with concurrent atorvastatin and diltiazem. Ann Pharmacother (2002) 0.79
The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist. Clin Ther (2003) 0.79
Thymosin β4: a potential novel dry eye therapy. Ann N Y Acad Sci (2012) 0.79
Cornea preservation time study: methods and potential impact on the cornea donor pool in the United States. Cornea (2015) 0.78
Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers. Clin Pharmacol Ther (2002) 0.78
Impact of genetic polymorphisms on clinical response to antithrombotics. Pharmgenomics Pers Med (2010) 0.77
Distinguishing anemia and iron deficiency of heart failure: signal for severity of disease or unmet therapeutic need? Pharmacotherapy (2014) 0.76
Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency. Pharmacotherapy (2014) 0.76
Expanding role of beta-blockade in the management of chronic heart failure. Pharmacotherapy (2003) 0.75
A Comparison of Self-reported Medication Adherence to Concordance Between Part D Claims and Medication Possession. Med Care (2017) 0.75
Advanced therapies for end-stage heart failure. Curr Cardiol Rev (2015) 0.75
Antiplatelet drug resistance: almost ready for prime time. Pharmacotherapy (2006) 0.75
Assessment of prescribers' knowledge of the cost of medications. Ann Pharmacother (2012) 0.75
A case report of simultaneous thrombosis of two coronary artery stents in association with clopidogrel resistance. Clin Cardiol (2007) 0.75
Cardiac transplantation in South Carolina: 300 transplants. J S C Med Assoc (2006) 0.75
Combination antiplatelet therapy: implications for pharmacists. Pharmacotherapy (2002) 0.75
Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction. Ann Pharmacother (2007) 0.75
Key articles related to complementary and alternative medicine in cardiovascular disease: part 1. Pharmacotherapy (2010) 0.75
Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update. Pharmacotherapy (2012) 0.75
Assessment of compliance with lipid guidelines in an academic medical center. Ann Pharmacother (2005) 0.75
Combination antiplatelet therapy: implications for pharmacists. J Am Pharm Assoc (Wash) (2002) 0.75
Reversible cardiomyopathy following treatment with amphotericin B and flucytosine. Int J Antimicrob Agents (2008) 0.75
High-impact articles related to the management of heart failure: 2008 update. Pharmacotherapy (2009) 0.75
Clopidogrel-proton pump inhibitor interaction: a primer for clinicians. Cardiovasc Hematol Disord Drug Targets (2010) 0.75
Glycoprotein IIb/IIIa receptor inhibitors in percutaneous coronary intervention and acute coronary syndrome. Ann Pharmacother (2003) 0.75
Role of race in the pharmacotherapy of heart failure. Ann Pharmacother (2002) 0.75
Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia. Pharmacotherapy (2006) 0.75
Perioperative management of antiplatelet therapy in patients with cardiovascular disease. Orthopedics (2008) 0.75
High-impact articles related to the pharmacotherapeutic management of systolic heart failure. Pharmacotherapy (2004) 0.75
Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial. Cornea (2015) 0.75
Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II® Left Ventricular Assist Device. ASAIO J (2017) 0.75
Cardiac transplantation at MUSC: 24 years of experience and change. J S C Med Assoc (2011) 0.75
Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomograms. Am J Health Syst Pharm (2011) 0.75
Epithelial Ingrowth Following Endothelial Keratoplasty. Cornea (2016) 0.75
Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatment. Pharmacotherapy (2007) 0.75
Rational use of diuretics in acute decompensated heart failure. Curr Heart Fail Rep (2008) 0.75
Heart failure management strategies in a surgical population. Orthopedics (2009) 0.75